StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
UPCUniverse Pharmaceuticals INC
stockpulse.co.kr
Nasdaq
$4.21▼ 3.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.7MShares out 0.7M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

19
  • 10.13Pre-market26.10.13 13:15filed
    EFFECTOther#●●●

    Universe Pharmaceuticals INC

    Universe Pharmaceuticals INC received SEC effectiveness approval for its registration statement (Form S-1) on October 9, 2026. This approval authorizes the company to proceed with the offering and sale of the registered securities.…more

    $4.21-3.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.6After-hours26.10.07 05:05
    6-KKey event

    Universe Pharmaceuticals INC

    Universe Pharmaceuticals approved the re-election of directors and a 1-for-10 reverse stock split at its 2026 Annual General Meeting held on September 30. The reverse split is set to be implemented if the company's closing bid price remains below $1.00 for three consecutive trading days within 12 months.…more

    $4.21-3.00%vs prev close
    View filingShare
  • 9.29After-hours26.09.30 05:11
    F-3Offering

    Universe Pharmaceuticals INC

    Universe Pharmaceuticals has filed a Form F-3 registration statement to offer up to $200 million in securities, including Class A ordinary shares, debt securities, and warrants, from time to time. The filing also covers the resale of 4,376,552 Class A ordinary shares by existing selling shareholders.…more

    $4.21-3.00%vs prev close
    View filingShare

18 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.29After-hours26.09.30 05:16
    Bullish#●●●#●●●

    Universe Pharmaceuticals Files Prospectus for $200M Mixed Shelf Offering…more

    Universe Pharmaceuticals has filed a prospectus for a $200 million mixed shelf offering and the sale of 4.377 million Class A ordinary shares by selling shareholders. This move indicates potential capital raising and share divestment, which may lead to equity dilution.…more

    $4.21-3.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.2Overnight26.09.02 16:45

    ●●●●●●●● ●●●●● ●●●●●●

    Universe Pharmaceuticals shares jumped in after-hours trading following filings revealing that eight investors hold over 5% stakes in the company. The disclosures are linked to shares issued for a patent acquisition, alongside a separate announcement regarding a proposed 1-for-10 reverse stock split.…more

    $4.21-3.00%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →